SastaSundar Ventures Aims for Profitable Comeback with Rs 150 Crore Investment
SastaSundar Ventures Ltd plans to invest Rs 150 crore to enhance its digital healthcare and warehousing capabilities, targeting a return to profit by FY'26. The investment, primarily funded by the Flipkart Health exit settlement, will focus on technology advancements, hiring, and the expansion of its B2C and B2B platforms.

- Country:
- India
SastaSundar Ventures Ltd is gearing up for a financial turnaround, planning to invest Rs 150 crore in its digital healthcare platform and warehousing infrastructure over the next two years. The company aims to return to profitability by FY'26, driven by strategic initiatives and capital-efficient growth.
The investment will be substantially funded through a Rs 145-crore pool, derived from the Flipkart Health exit settlement and internal treasury income. Earlier this year, the Kolkata-based online pharmacy ended its partnership with Flipkart Health and relaunched its B2C platform under its own brand.
SastaSundar has launched JITO, a customized generics medicine channel under its main brand, to meet the increasing demand for affordable medication. A Rs 50-crore investment is also planned for technology and AI-driven healthcare tools to double its B2C business by FY'26.
(With inputs from agencies.)